{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:42:11Z","timestamp":1762638131122,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jtocrr.2025.100823","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T13:20:02Z","timestamp":1741612802000},"page":"100823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9493-7221","authenticated-orcid":false,"given":"Margaret","family":"Stalker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Lebow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily Ling-Lin","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Banihashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Roshkovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharyn I.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Litzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey J.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Cengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina E.","family":"Marmarelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2025.100823_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20360","article-title":"Assessment of global trends in the diagnosis of mesothelioma from 1990 to 2017","volume":"4","author":"Zhai","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtocrr.2025.100823_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtocrr.2025.100823_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.annonc.2022.01.074","article-title":"First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743","volume":"33","author":"Peters","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2025.100823_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtho.2021.07.029","article-title":"Nivolumab plus ipilimumab should be the standard of care for first-line unresectable epithelioid mesothelioma","volume":"17","author":"Baas","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2025.100823_bib7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1186\/s12885-020-07662-y","article-title":"Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease","volume":"20","author":"Collins","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtocrr.2025.100823_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1378\/chest.11-3204","article-title":"Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients","volume":"142","author":"Finn","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtocrr.2025.100823_bib9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1513\/AnnalsATS.201404-165BC","article-title":"Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review","volume":"11","author":"Miller","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jtocrr.2025.100823_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/WCO.0000000000000756","article-title":"Complications associated with immunotherapy for brain metastases","volume":"32","author":"Tran","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jtocrr.2025.100823_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219199120","article-title":"Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models","volume":"120","author":"Datta","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtocrr.2025.100823_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s40425-019-0684-z","article-title":"Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy","volume":"7","author":"Tran","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jtocrr.2025.100823_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpba.2018.10.025","article-title":"Enzyme linked immunosorbent assay for the quantification of nivolumab and pembrolizumab in human serum and cerebrospinal fluid","volume":"164","author":"Pluim","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jtocrr.2025.100823_bib14","doi-asserted-by":"crossref","first-page":"CNS93","DOI":"10.2217\/cns-2022-0014","article-title":"Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure","volume":"12","author":"Tringale","year":"2023","journal-title":"CNS Oncol"},{"key":"10.1016\/j.jtocrr.2025.100823_bib15","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1200\/EDBK_100005","article-title":"Immune checkpoint inhibitors in brain metastases: from biology to treatment","volume":"35","author":"Berghoff","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"author":"Drappatz","key":"10.1016\/j.jtocrr.2025.100823_bib16"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364325000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364325000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:39:00Z","timestamp":1762637940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364325000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2666364325000396"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2025.100823","relation":{},"ISSN":["2666-3643"],"issn-type":[{"type":"print","value":"2666-3643"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2025.100823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100823"}}